Mitchell & Pahl Private Wealth’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $830K | Buy |
|
|||||
|
2025
Q2 | $951K | Buy |
|
|||||
|
2025
Q1 | $900K | Buy |
|
|||||
|
2024
Q4 | $1.08M | Buy |
|
|||||
|
2024
Q3 | $1.45M | Buy |
|
|||||
|
2024
Q2 | $1.73M | Sell |
|
|||||
|
2024
Q1 | $1.58M | Buy |
|
|||||
|
2023
Q4 | $1.25M | Sell |
|
|||||
|
2023
Q3 | $1.11M | Buy |
|
|||||
|
2023
Q2 | $919K | Sell |
|
|||||
|
2023
Q1 | $921K | Buy |
|
|||||
|
2022
Q4 | $775K | Buy |
|
|||||
|
2022
Q3 | $558K | Buy |
|
|||||
|
2022
Q2 | $581K | Buy |
|
|||||
|
2022
Q1 | $524K | Buy |
|
|||||
|
2021
Q4 | $447K | Buy |
|
|||||
|
2021
Q3 | $355K | Buy |
|
|||||
|
2021
Q2 | $304K | Buy |
|
|||||
|
2021
Q1 | $226K | Buy |
|
|||||
|
2020
Q4 | $227K | Buy |
|